Jeremy Hill, a managing director at JPMorgan Chase & Co. who gave his time and money to support young people with cancer before being diagnosed with an advanced case of it himself, has died. He was 43.
Hill, who was co-head of global equity finance, a unit within the New York-based bank’s Prime Brokerage business, died March 7 of melanoma, the most lethal form of skin cancer, according to a death notice in the New York Times.
A New Zealander who lived in Manhattan, he served on the board of the SAMFund, a Boston-based nonprofit group that offers grants to help young adults transition to life after cancer.
Its executive director, Samantha Eisenstein Watson, contacted Hill early in 2007 after he sent a $500 donation, she said yesterday in an interview. Though he had been “touched in his own life” by family members and friends who had cancer, Watson recalled, Hill wrote in his first e-mail to her that he hadn’t before considered the “financial ramifications” of cancer on young people.
“He just had this way of being able to put himself in other people’s shoes,” Watson said.
In fact, Hill had undergone treatment for a skin growth that raised the prospect of cancer, “but his level of involvement and his graciousness in giving was way outsized to the scare that he experienced very briefly in that era,” according to Greg Levi, a friend and former classmate at the University of Chicago’s Booth School of Business.
Joined Second Board
By the time Hill received his more serious diagnosis, he was involved with both the SAMFund and the NYU Cancer Institute at New York University Langone Medical Center in New York City. He was named to the Cancer Institute’s advisory board in 2010.
The board includes billionaires Kenneth G. Langone, co-founder of Home Depot Inc., and Thomas H. Lee, the financier who heads New York-based Lee Equity Partners LLC. The goal of the institute is to “discover the origins of human cancer” and “eradicate the personal and societal burden” of the disease, according to its website.
Lori Fink, chairman of the board of advisers, said yesterday in an interview that when she met Hill in 2010, he believed his own cancer scare was behind him.
“He felt he had his life ahead of him, this had been taken care of, and he wanted to be an upstanding citizen and make a difference,” Fink said. Her husband, Laurence D. Fink, chief executive officer of BlackRock Inc., the world’s biggest asset manager, is co-chairman of the hospital’s board of trustees.
Also in 2010, Hill hosted -- and was guest bartender at -- a SAMFund fundraiser at the Public House bar and restaurant in Manhattan. In addition to raising money, the event introduced the group to new supporters from Wall Street and the New York metropolitan area, Watson said.
Watson said she was among the select group of people with whom Hill shared news of his diagnosis and battle.
“An incredibly private person, he trusted me with his story and I was grateful and determined to support him as best I could,” Watson wrote March 8 in a blog posting. She said she traveled to New York the week before to see him one final time.
Jeremy Michael Hill was born on Nov. 6, 1968, according to an obituary in the New Zealand Herald. Survivors include his mother, Maureen, and two brothers, Antony and Tim. His father, Tom, predeceased him, according to death notices in the New York Times.
He earned a bachelor of commerce degree from the University of Auckland and a master’s degree in business administration from the University of Chicago’s Booth School of Business, according to the NYU Cancer Institute.
Prior to JPMorgan, Hill was a senior managing director and global head of equity finance at Bear Stearns Cos., according to the NYU Cancer Institute. JPMorgan acquired Bear Stearns in 2008. He worked at the two banks for a combined 17 years, Elizabeth Seymour, a JPMorgan spokeswoman, said.
“Jeremy was a leader in our Prime Brokerage business,” Hill’s management team said in a March 8 memo to the staff. “He was a valued colleague, talented professional and dear friend. We will miss him immensely.”